Skip to main content
MedPathMedPath Home
Clinical Trials/PACTR202109892575291
PACTR202109892575291
Completed
Phase 3

The Effect of Intravenous Infusion of Dexmedetomidine versus Lidocaine as an Analgesic Adjuvant to Balanced General Anesthesia and Enhanced Recovery After Abdominal Surgery

Not provided0 sites140 target enrollmentSeptember 21, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Not provided
Enrollment
140
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 21, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Not provided

Eligibility Criteria

Inclusion Criteria

  • •Patients (age 21\-55 years)
  • •With body mass index (BMI) 18\-25 Kg/m2\.
  • •ASA 1 and ASA 2 patients
  • •Adequate cognitive state (able to understand and collaborate).
  • •Patients that will undergo elective open abdominal surgery

Exclusion Criteria

  • •Hypersensitivity to any of the used drugs
  • •Pregnancy and lactating mothers
  • •Chronic pain requiring daily use of opioid medication or chronic alcohol abuser
  • •Sleep apnea syndrome.
  • •Bradycardia (heart rate of fewer than 50 beats per min at rest) or patients on beta\-blockers or alpha 2 agonists.
  • •Epilepsy or chronic daily use of psychiatric medication
  • •Patients received any other regional anesthesia technique (epidural, transverse abdominis plane (TAP) and Plexus block)
  • •Re\-exploration cases

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 3
Effect of intravenous infusion of dexmedetomidine with magnesium sulfate on control of bleeding and surgeon satisfaction during tympanoplasty surgeryPerforation of tympanic membrane.Perforation of tympanic membrane
IRCT20120215009014N427Hamedan University of Medical Sciences40
Completed
Not Applicable
Effect of of dexmedetomidine in control bleeding during sinus surgery
IRCT2017012929256N2Vice-Chancellor for Research and Technology of Ahvaz Jundishapur University of Medical Sciences60
Completed
Not Applicable
Studying the effect of intravenous dexmedetomidine on spinal anaesthesia with bupivacaine. Dexmedetomidine is an alpha agonist drug known to prolong the effects of spinal anaesthesia. Bupivacaine is a local anaesthetic.Health Condition 1: null- American Society of Anaesthesiologists Physical Status 1 or 2
CTRI/2015/01/005431Manipal University75
Not yet recruiting
Phase 3
Effects of intravenous dexmedetomidine on spinal anesthesia in surgeries below umbilicus.
CTRI/2024/07/070219SDM college of medical sciences an d hospital
Recruiting
Not Applicable
TO KNOW THE EFFECT OF DRUG DEXMEDETOMEDINE ON BLOOD LOSS DURING BRAIN SURGERY IN COMPARISION TO NORMAL SALINE: A RANDOMIZED CONTROLLED TRIAHealth Condition 1: null- PATIENTS POSTED FOR ELECTIVE INTRACRANIAL MENINGIOMA SURGERY. OTHERWISE HEALTHY PATIENT
CTRI/2018/04/013433AIIMS NEW DELHI